Legacy Pharma Invest GP

Private Equity Exempt reporting adviser

Legal name: Legacy Pharma Invest GP Inc.

Toronto, On, Canada

AUM

$25.0M
Private fund assets

Private funds

1
Private Equity 1

Private fund assets

$25.0M
Gross asset value

Employees

—

Last Form D raise

Oct 2023
Most recent fund filing

From SEC Form ADV filing (filed Mar 27, 2026). View on SEC

People(2)

Owners and executive officers named on the firm's SEC Form ADV.

A
Andrew Lapham
Director and Officer
Source: SEC Form ADV
J
James Albrecht
Director and Officer
Source: SEC Form ADV

Funds(1)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Legacy Pharma Invest LPPrivate Equity$25.0M——Oct 2023Cold

Board seats

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

No board seats matched from SEC filings yet.

Regulatory identifiers

CRD number
329146
SEC file number
802-129460

Sources